Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Grudziądz
Clinical trial register · Poland

Clinical Trials in Grudziądz, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 1315 Krakow 882 Poznan 705 Gdansk 657 Lodz 619
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca8 Hoffmann-La Roche4 Merck Sharp & Dohme LLC3 Eli Lilly and Company3 Novartis Pharmaceuticals2
Site location
Warsaw1315 Krakow882 Poznan705 Gdansk657 Lodz619
All 264 locations
Target enrolment
to

Trials with a site in Grudziądz

30 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Panuri Performance Study
NCT07587866Pancreatic Ductal Adenocarcinoma (PDAC)
Urteste S.A
Observational
1,100
Dąbrowa Tarnowska, Gdansk, Grudziądz, Iława, Krakow, Lodz, Lublin, Malbork
2026-06-10
Not yet open
Novo Nordisk A/S
Phase 3
1,000
Lublin, Grudziądz, Bialystok, Elblag, Gorzów Wielkopolski, Kalwaria Zebrzydowska, Krakow, Legnica
2026-05-20
Recruiting
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.
Phase 3
1,703
Bialystok, Bydgoszcz, Gdansk, Grudziądz, Katowice, Krakow, Lodz, Nowa Sól
2025-11-25
Recruiting
Eli Lilly and Company
Phase 3
1,205
Bydgoszcz, Elblag, Grudziądz, Komorniki, Leszno, Puławy, Wroclaw
2025-10-31
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Bielsko-Biala, Bydgoszcz, Elblag, Grudziądz, Katowice, Komorniki, Krakow, Leszno
2025-09-02
Recruiting
Neurocrine Biosciences
Phase 3
850
Bełchatów, Bialystok, Bydgoszcz, Gdansk, Grudziądz, Katowice
2025-04-16
Active, closed
A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
NCT06680817Neovascular Age-related Macular Degeneration, Diabetic Macular Edema
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
875
Bielsk Podlaski, Grudziądz, Lodz, Poznan, Szczecin, Wejherowo, Zielona Góra
2025-02-05
Active, closed
Pfizer
Phase 3
600
Grudziądz, Torun, Krakow, Wroclaw, Opole, Koszalin
2024-10-21
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Bydgoszcz, Gdansk, Gorlice, Grudziądz, Katowice, Leszno, Poznan, Warsaw
2024-07-25
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Bydgoszcz, Grudziądz, Gorlice, Krakow, Poznań, Lublin, Warsaw, Przemyśl
2024-06-10
Active, closed
Eli Lilly and Company
Phase 3
17,300
Bialystok, Bydgoszcz, Chrzanów, Dąbrowa Górnicza, Elblag, Gdansk, Grudziądz, Katowice
2024-03-05
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Bydgoszcz, Grudziądz, Torun, Siedlce, Koszalin, Szczecin, Kielce
2023-12-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Bydgoszcz, Grudziądz, Torun, Krakow, Warsaw, Przemyśl, Olsztyn, Lodz
2023-12-15
Recruiting
AstraZeneca
Phase 3
4,300
Bialystok, Grudziądz, Koszalin, Lodz, Lublin, Opole, Poznan, Racibórz
2023-03-31
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Krakow, Bialystok, Bydgoszcz, Bygdoszcz, Chorzów, Elblag, Gdynia, Grudziądz
2023-03-09
Active, closed
Hoffmann-La Roche
Phase 3
1,290
Tarnów, Lodz, Bia?ystok, Bydgoszcz, Chojnice, Gdynia, Grudzadz, Grudziądz
2022-12-29
Active, closed
AstraZeneca
Phase 3
1,350
Bydgoszcz, Bystra, Grudziądz, Kielce, Koszalin, Olsztyn, Poznan, Przemyśl
2022-12-29
Recruiting
Wroclaw Medical University
Phase 4
1,000
Bydgoszcz, Grudziądz, Torun, Chrzanów, Gorlice, Krakow, Nowy Targ, Oświęcim
2022-09-22
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Bydgoszcz, Gdynia, Gliwice, Grudziądz, Krakow, Lodz, Lublin, Poznan
2021-08-27
Active, closed
Hoffmann-La Roche
Phase 1
119
Grudzi?dz, Poznan, Szczecin, Zabrze
2021-08-11
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Gdynia, Grudziądz, Kobylniki, Koszalin, Krakow, Poznan, Warsaw, Wroclaw
2021-03-18
Active, closed
Pfizer
Phase 3
1,068
Gliwice, Grudziądz, Mysłowice, Piotrkow Trybunalski, Poznan, Skierniewice, Warsaw, Wroclaw
2019-12-30
Active, closed
AstraZeneca
Phase 1
175
Bialystok, Bydgoszcz, Gdansk, Grudziądz, Lodz, Olsztyn, Tomaszów Mazowiecki, Warsaw
2018-12-27
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Warsaw, Bialystok, Gdynia, Gliwice, Grudziądz, Krakow, Lodz, Lublin
2018-12-07
Active, closed
AstraZeneca
Phase 3
1,063
Bialystok, Gdansk, Grudziądz, Koszalin, Krakow, Olsztyn, Ostrołęka, Poznan
2018-11-16
Active, closed
AstraZeneca
Phase 3
1,246
Bialystok, Gdansk, Grudziądz, Koszalin, Krakow, Olsztyn, Poznan, Radom
2018-09-27
Recruiting
BioInvent International AB
Phase 1/2
140
Grudziądz, Krakow
2018-05-16
Active, closed
AstraZeneca
Phase 3
1,018
Bialystok, Gdansk, Grudziądz, Koszalin, Piotrkow Trybunalski, Poznan, Warsaw, Wroclaw
2018-05-14
Active, closed
AstraZeneca
Phase 3
669
Bialystok, Grudziądz, Koszalin, Lublin, Mrozy, Warsaw, Wroclaw
2017-01-02
Active, closed
AstraZeneca
Phase 3
510
Brzozów, Bydgoszcz, Gdansk, Grudziądz, Krakow, Lubin, Olsztyn, Opole
2013-09-25
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/grudzi-dz

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies with a site in Grudziądz.

How many clinical trials are recruiting in Grudziądz?

12 of the 30 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 17 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Grudziądz), 30 studies
PhaseStudiesRecruitingShare
Phase 324980%
Observational216.7%
Phase 1206.7%
Phase 1/2113.3%
Phase 4113.3%

Most active sponsors

Lead sponsors with the most studies (Grudziądz)
Lead sponsorStudiesRecruiting
AstraZeneca81
Hoffmann-La Roche40
Eli Lilly and Company32
Merck Sharp & Dohme LLC33
Novartis Pharmaceuticals20
Pfizer20
BioInvent International AB11
Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.11
Janssen Research & Development, LLC11
Jiangsu HengRui Medicine Co., Ltd.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.